Darwin Wealth Management’s Boston Scientific BSX Stock Holding History

Darwin Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.7K	Sell	1,188 -22,526	-95%	-$1.22M	0.01%	230
2026 Q1	$1.49M	Buy	23,714 +7,438	+46%	+$595K	0.46%	64
2025 Q4	$1.55M	Buy	16,276 +3,021	+23%	+$296K	0.48%	59
2025 Q3	$1.29M	Buy	13,255 +705	+6%	+$73K	0.41%	66
2025 Q2	$1.35M	Sell	12,550 -5,087	-29%	-$515K	0.47%	64
2025 Q1	$1.58M	Hold	17,637	–	–	0.53%	55
2024 Q4	$1.58M	Sell	17,637 -6,999	-28%	-$616K	0.53%	55
2024 Q3	$2.06M	Buy	+24,636	New	+$1.94M	0.57%	59
2020 Q2	–	Sell	-1,200	Closed	-$39K	–	226
2020 Q1	$39K	Buy	+1,200	New	+$46.9K	0.01%	268

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Darwin Wealth Management's BSX Position: Q2 2026 in Review

Darwin Wealth Management reduced its Boston Scientific (BSX) stake by 95% in Q2 2026, selling an estimated $1.22M and leaving 1,188 shares worth $50.7K. The position accounts for 0.01% of the portfolio, ranked #230.

Darwin Wealth Management first reported a position in BSX in Q1 2020 and has held it in 9 quarters since. The position peaked at $2.06M in Q3 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Darwin Wealth Management held 1,188 shares of Boston Scientific worth $50.7K as of Q2 2026.
Darwin Wealth Management sold 22,526 Boston Scientific shares in Q2 2026, an estimated $1.22M.
Boston Scientific made up 0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #230 holding.
Darwin Wealth Management first reported a position in Boston Scientific in Q1 2020 and has held it in 9 quarters since.
Darwin Wealth Management's Boston Scientific position peaked at $2.06M in Q3 2024.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.